Immunologic markers in the neonatal period: diagnostic value and accuracy in infection

Area of Science:

• Neonatal immunology
• Infectious disease diagnostics
• Biomarker research

Background:

• Early-onset neonatal infection diagnosis relies on markers like C-reactive protein (CRP) and cytokines (IL-6, IL-8).
• These markers increase in response to infection, sometimes preceding CRP elevation.
• Novel biomarkers are sought to improve diagnostic accuracy in newborns.

Purpose of the Study:

• To review the role of emerging immunologic markers in neonatal infection diagnosis.
• To assess the validity of procalcitonin and leukocyte cell surface antigens (CD11b, CD64) as diagnostic markers.
• To compare these new markers with established ones like CRP and cytokines.

Main Methods:

• Literature review of studies on immunologic markers for neonatal infection.
• Analysis of data on C-reactive protein, interleukin-6, interleukin-8, procalcitonin, CD11b, and CD64.
• Evaluation of diagnostic performance and clinical utility of these markers.

Main Results:

• Procalcitonin shows promise as a sensitive marker for bacterial infections in neonates.
• Elevated expression of leukocyte antigens (CD11b, CD64) indicates bacterial activation.
• Combined use of markers may enhance diagnostic accuracy compared to single markers.

Conclusions:

• Procalcitonin and specific leukocyte antigens represent valuable additions to the diagnostic arsenal for neonatal infections.
• These markers offer potential for earlier and more accurate diagnosis than traditional methods alone.
• Further research is needed to establish optimal protocols for their clinical application.